Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126376931 | 12637693 | 1 | I | 2008 | 20160208 | 20160809 | 20160809 | PER | US-ABBVIE-16P-163-1557047-00 | ABBVIE | 32.08 | YR | F | Y | 83.99000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126376931 | 12637693 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | AT BEDTIME | Y | N | 18723 | 500 | MG | CAPSULE | QD | ||||
| 126376931 | 12637693 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | AT BEDTIME | Y | UNKNOWN | 0 | 75 | MG | CAPSULE | QD | ||||
| 126376931 | 12637693 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | AT BEDTIME | Y | UNKNOWN | 0 | 75 | MG | CAPSULE | QD | ||||
| 126376931 | 12637693 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | Y | 0 | BID | |||||||||
| 126376931 | 12637693 | 5 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | 1 | MG | BID | ||||||||
| 126376931 | 12637693 | 6 | C | VALIUM | DIAZEPAM | 1 | Oral | 0 | 5 | MG | BID | ||||||||
| 126376931 | 12637693 | 7 | C | VALIUM | DIAZEPAM | 1 | 0 | ||||||||||||
| 126376931 | 12637693 | 8 | C | NIRVAM | 2 | Oral | ODT (DISOLVING) | 0 | 2 | MG | |||||||||
| 126376931 | 12637693 | 9 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | QHS | 0 | |||||||||||
| 126376931 | 12637693 | 10 | C | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | QHS | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126376931 | 12637693 | 1 | Depression |
| 126376931 | 12637693 | 2 | Fibromyalgia |
| 126376931 | 12637693 | 4 | Fibromyalgia |
| 126376931 | 12637693 | 5 | Anxiety disorder |
| 126376931 | 12637693 | 6 | Post-traumatic stress disorder |
| 126376931 | 12637693 | 7 | Anxiety disorder |
| 126376931 | 12637693 | 8 | Anxiety |
| 126376931 | 12637693 | 9 | Insomnia |
| 126376931 | 12637693 | 10 | Affective disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126376931 | 12637693 | Amnesia | |
| 126376931 | 12637693 | Bedridden | |
| 126376931 | 12637693 | Depression | |
| 126376931 | 12637693 | Drug dose omission | |
| 126376931 | 12637693 | Drug ineffective | |
| 126376931 | 12637693 | Dyspepsia | |
| 126376931 | 12637693 | Feeling hot | |
| 126376931 | 12637693 | Fibromyalgia | |
| 126376931 | 12637693 | Gastrooesophageal reflux disease | |
| 126376931 | 12637693 | Hypertension | |
| 126376931 | 12637693 | Hypoaesthesia | |
| 126376931 | 12637693 | Mobility decreased | |
| 126376931 | 12637693 | Movement disorder | |
| 126376931 | 12637693 | Pain | |
| 126376931 | 12637693 | Paraesthesia | |
| 126376931 | 12637693 | Somnolence | |
| 126376931 | 12637693 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126376931 | 12637693 | 1 | 2008 | 201505 | 0 | |
| 126376931 | 12637693 | 2 | 201505 | 201601 | 0 | |
| 126376931 | 12637693 | 3 | 2016 | 0 | ||
| 126376931 | 12637693 | 4 | 20160101 | 20160129 | 0 | |
| 126376931 | 12637693 | 5 | 2000 | 0 | ||
| 126376931 | 12637693 | 6 | 2008 | 0 | ||
| 126376931 | 12637693 | 8 | 2008 | 0 | ||
| 126376931 | 12637693 | 9 | 2008 | 201507 | 0 | |
| 126376931 | 12637693 | 10 | 2008 | 0 |